Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov (English)
- New search for: Stockmann, C.
- New search for: Sherwin, C. M.
- New search for: Ampofo, K.
- New search for: Hersh, A. L.
- New search for: Pavia, A. T.
- New search for: Byington, C. L.
- New search for: Ward, R. M.
- New search for: Spigarelli, M. G.
- New search for: Stockmann, C.
- New search for: Sherwin, C. M.
- New search for: Ampofo, K.
- New search for: Hersh, A. L.
- New search for: Pavia, A. T.
- New search for: Byington, C. L.
- New search for: Ward, R. M.
- New search for: Spigarelli, M. G.
In:
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
;
42
, 2
;
161-166
;
2013
-
ISSN:
- Article (Journal) / Print
-
Title:Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov
-
Contributors:Stockmann, C. ( author ) / Sherwin, C. M. ( author ) / Ampofo, K. ( author ) / Hersh, A. L. ( author ) / Pavia, A. T. ( author ) / Byington, C. L. ( author ) / Ward, R. M. ( author ) / Spigarelli, M. G. ( author )
-
Published in:INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS ; 42, 2 ; 161-166
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2013-01-01
-
Size:6 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 579
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 579 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 42, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 99
-
New antibiotics for paediatric use: A review of a decade of regulatory trials submitted to the European Medicines Agency from 2000-Why aren't we doing better?Garazzino, S. / Lutsar, I. / Bertaina, C. / Tovo, P. A. / Sharland, M. et al. | 2013
- 119
-
Management of herpesvirus infectionsEvans, C. M. / Kudesia, G. / McKendrick, M. et al. | 2013
- 129
-
Effect of ribosome-targeting antibiotics on streptomycin-resistant Mycobacterium mutants in the rpsL genePelchovich, G. / Zhuravlev, A. / Gophna, U. et al. | 2013
- 133
-
The tetA gene decreases tigecycline sensitivity of Salmonella enterica isolatesAkiyama, T. / Presedo, J. / Khan, A. A. et al. | 2013
- 141
-
Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978Lai, M. J. / Soo, P. C. / Lin, N. T. / Hu, A. / Chen, Y. J. / Chen, L. K. / Chang, K. C. et al. | 2013
- 149
-
Pharmacokinetic analysis of doripenem in elderly patients with nosocomial pneumoniaHarada, M. / Inui, N. / Suda, T. / Nakamura, Y. / Wajima, T. / Matsuo, Y. / Chida, K. et al. | 2013
- 155
-
Evaluating amikacin dosage regimens in intensive care unit patients: A pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulationZazo, H. / Martin-Suarez, A. / Lanao, J. M. et al. | 2013
- 161
-
Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.GovStockmann, C. / Sherwin, C. M. / Ampofo, K. / Hersh, A. L. / Pavia, A. T. / Byington, C. L. / Ward, R. M. / Spigarelli, M. G. et al. | 2013
- 167
-
Characterisation of plasmids implicated in the mobilisation of extended-spectrum and AmpC b-lactamase genes in clinical Salmonella enterica isolates and temporal stability of the resistance genotypede Toro, M. / Garcia, P. / Rodriguez, I. / Rojo-Bezares, B. / Helmuth, R. / Saenz, Y. / Rodicio, M. R. / Guerra, B. / Torres, C. et al. | 2013
- 173
-
Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008Yang, H. / Duan, G. / Zhu, J. / Zhang, W. / Xi, Y. / Fan, Q. et al. | 2013
- 178
-
Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumanniiLuque, S. / Grau, S. / Valle, M. / Sorli, L. / Horcajada, J. P. / Segura, C. / Alvarez-Lerma, F. et al. | 2013
- 182
-
Anti-inflammatory and immunomodulatory activities of rifamycin SVRosette, C. / Buendia-Laysa, F. / Patkar, S. / Moro, L. / Celasco, G. / Bozzella, R. / Ajani, M. / Gerloni, M. et al. | 2013
- 187
-
Mechanisms of fluoroquinolone resistance in Vibrio parahaemolyticusLiu, M. / Wong, M. H. / Chen, S. et al. | 2013
- 188
-
High rates of reduced susceptibility in the Bacteroides fragilis group isolated from blood cultures - The first national survey in DenmarkJustesen, U. S. / Hansen, F. / Ostergaard, C. / Schonheyder, H. C. / Hansen, D. S. / Lemming, L. E. / Schumacher, H. / Heltberg, O. / Knudsen, J. D. / Dzajic, E. et al. | 2013
- 190
-
Treatment of Staphylococcus aureus endocarditis with high doses of trimethoprim/sulfamethoxazole and clindamycin-Preliminary reportCasalta, J. P. / Zaratzian, C. / Hubert, S. / Thuny, F. / Gouriet, F. / Habib, G. / Grisoli, D. / Deharo, J. C. / Raoult, D. et al. | 2013
- 191
-
Extensive investigation of antimicrobial resistance in Vibrio parahaemolyticus from shellfish and clinical sources, ItalyOttaviani, D. / Leoni, F. / Talevi, G. / Masini, L. / Santarelli, S. / Rocchegiani, E. / Susini, F. / Montagna, C. / Monno, R. / D'Annibale, L. et al. | 2013
-
Editorial Board| 2013